A COMPREHENSIVE REVIEW ON THE INTERNAL ADMINISTRATION OF CHITRAKA AS AN INGREDIENT MENTIONED IN CLASSICAL TEXTS OF AYURVEDA

Sariga K S; Chetan K Kamble; Rabinarayan Acharya

doi:10.51649/healer.65

Dr.Sariga K S PhD scholar
Dr.Chetan K Kamble
Prof.Rabinarayan Acharya

Keywords: Agni, Chitraka, Chirata, Deepana, Pachana, Plumbago

Abstract

Background: Chitraka is one of the well-known drug of Ayurveda Pharmacopoeia and is popular for its Deepana-Pachana properties. It is commonly used for the diseases of gastrointestinal tract where there is an impairment of digestive fire. The drug Chitraka is used as ingredient of many formulations which are used internally, externally for therapeutic purposes or as used as a media for purification of certain mineral drugs in Ayurveda. Aim: Review and documentation of indication of Chitraka as an ingredient for internal administration from various Ayurveda books. Materials and methods: Review was carried out from 50 Ayurveda texts which includes Samhitas, Chikitsa grantas and Rasa Grantas. Results: In available classical Ayurvedic compendia 2631 formulations were found containing Chitraka as an ingredient for internal administration. These formulations are available in 37 dosage forms, among which maximum are of Churna form followed by Vati, Ghrita, Kwatha, Avaleha etc. Chitraka containing formulations are found indicated in the treatment of more than 130 disorders, out of which maximum are indicated in Arsa, Jwara and Kushtha. The maximum formulations are found in Anna-Purishavaha Srotasa. Conclusion: Chitraka is used in 2631 formulations being prepared in 37 dosage forms and is being indicated in more than 130 disease conditions. Outcomes of the present review may provide ideas for more research on finding out inclusion of Chitraka in many formulations.

Materials and methods: Review was carried out from 50 Ayurveda texts which includes Samhitas, Chikitsa grantas and Rasa Grantas.

Results: In available classical Ayurvedic compendia 2631 formulations were found containing Chitraka as an ingredient for internal administration. These formulations are available in 37 dosage forms, among which maximum are of Churna form followed by Vati, Ghrita, Kwatha, Avaleha etc. Chitraka containing formulations are found indicated in the treatment of more than 130 disorders, out of which maximum are indicated in Arsa, Jwara and Kushtha. The maximum formulations are found in Anna-Purishavaha Srotasa.

Conclusion: Chitraka is used in 2631 formulations being prepared in 37 dosage forms and is being indicated in more than 130 disease conditions. Outcomes of the present review may provide ideas for more research on finding out inclusion of Chitraka in many formulations.